background: Given the significant drawbacks of using human embryonic stem (hES) cells for regenerative medicine, the search for alternative sources of multipotent cells is ongoing. Studies in mice have shown that multipotent ES-like cells can be derived from neonatal and adult testis. Here we report the derivation of ES-like cells from adult human testis. methods: Testis material was donated for research by four men undergoing bilateral castration as part of prostate cancer treatment.
Introduction
Since their discovery, human embryonic stem (hES) cells have had the prospect of being the savior for patients suffering from diseases that result from specific cell loss or damage such as Alzheimer's disease, Parkinson's disease, spinal cord injury, diabetes and cancer (Cowan et al., 2004) . Two major drawbacks have precluded their use in clinical settings thus far. First, hES cells are derived from human embryos and are therefore not genetically identical to the person for whom they are destined to be used. As a consequence, transplantation of such cells will invoke immune rejection and constituent immune suppression will be necessary to allow the transplanted cells to survive.
Second, the generation of hES cells entails the destruction of human preimplantation embryos, which is considered ethically unacceptable by many members of society.
As a result of these drawbacks, researchers have focused on finding alternative sources of multipotent cells in the adult human body. Recently, induced pluripotent stem cells (iPS cells) have successfully been derived from adult and fetal human fibroblasts (Takahashi et al., 2007; Lowry et al., 2008; Mali et al., 2008; Nakagawa et al., 2008; Park et al., 2008) . However, their generation currently requires viral transduction with transcription factors, sometimes including c-myc, a well-known oncogene (Hyun et al., 2007; Nakagawa et al., 2008; Wernigr et al., 2008) . As a consequence, extensive studies will be needed to ascertain the actual potency of iPS cells and to control their elevated tumorigenic potential (Gearhart et al., 2007; Hyun et al., 2007) .
Spermatogonial stem cells from neonatal and adult mice are able to develop into multipotent cells when cultured under specific conditions in vitro (Kanatsu-Shinohara et al., 2004; Guan et al., 2006; Seandel et al., 2007; de Rooij and Mizrak, 2008) . In addition, efficient and longterm culture of spermatogonial stem cells is now possible allowing sufficient cells for regenerative therapy to be generated (Kanatsu-Shinohara et al., 2003) .
Very recently, three groups have independently found formation of ES-like cells by exposing human testicular cells to specific ES conditions in vitro (Conrad et al., 2008; Golestaneh et al., 2009; Kossack et al., 2009) . Here, we show that ES-like cells can also be generated under culture conditions known to support long-term proliferation of spermatogonial stem cells (SSCs).
Materials and Methods

Testicular cell isolation and culture
After written informed consent, testis material was donated for research by four men undergoing bilateral castration as part of prostate cancer treatment. Testicular cells were isolated by enzymatic digestion (trypsine, collagenase and hyaluronidase in MEM-containing DNase) and cultured in supplemented StemPro-34 medium as previously described for mouse testicular cells (Kanatsu-Shinohara et al., 2003) , but, importantly, with the omission of feeder cells. When somatic cells, originated from the testicular cell isolation, tended to overgrow the culture, differential passaging was performed. After their initial appearance, sharp-edged, compact colonies, which morphologically resembled ES colonies, were picked and subcultured as described earlier (Xu et al., 2001 ) with some modifications. Briefly, individual colonies were subcultured, after collection from the main cultures, again without feeder cells, in ES cell medium (DMEM-KO medium), 20% ES qualified FCS, 2-mM L-glutamine, 1% non-essential amino acids, 1Â Insulin-Transferrin-Selenium (all Gibco, Carlsbad, CA), 25-ng/ml bFGF and 0.1-mM b-mercaptoethanol (both, Sigma, St. Louis, MO) on Matrigel (Becton Dickinson, Bedford, MA) coated culture dishes. Cells were split each week 1:3 by scraping and transferring them to new matrigel-coated dishes and the cells were successfully frozen-thawed multiple times. Human ES cells used as controls (line ES[4]) were cultured as described elsewhere (Raya et al., 2008) .
To study the potency of these testis-derived ES-like cells, in vitro directed differentiation was applied to obtain derivatives of all three germ layers. Differentiation into epidermal (Bagutti et al., 1996) , neural (Strubing et al., 1995) and osteogenic cells (Sottile et al., 2003) was performed following the hanging drop method. Differentiation into myogenic cells was induced with the addition of 1% DMSO in the medium (Zheng et al., 2006) . Pancreatic cell lineage differentiation was performed as described previously (Baharvand et al., 2006) , but with omission of nestinpositive cell selection.
Characterization of undifferentiated and differentiated testis-derived ES-like cells
RT-PCR
RNA was extracted from testis-derived ES-like cells, testis tissue and ES [4] human ES cells. A quantity of 1 mg of total RNA from hES cells or germline stem cells or 0.03 mg of mRNA from testis tissue was used in a reverse transcriptase reaction with random primers and M-MLV reverse transcriptase (Invitrogen Carlsbad, CA). PCR amplification was performed using gene-specific forward and reverse primers (Supplementary Table S1) as follows: 3 min at 948C followed by 35 cycles of 1 min at 948C, 1 min at a specific annealing temperature for each primer (Pou5f1 [touchdown 70, 69, 68, 66, 64, 62, 60, 58, 57 (28x) Embryonic stem cell-like cells from human testis were pretreated with 0.1% Triton X-100. After incubation of primary antibodies and washing, cells were incubated with rabbit anti-mouse FITC (F 7506, Sigma) for SSEA4, SSEA1, Tra-1-60, TRA-1-81, donkey anti-goat FITC (Jackson, Maine) for POU5F1 and SOX2 and goat anti-rat Alexa 488 (A11 006, Molecular Probes, Carlsbad, CA) for NANOG. As negative control isotype, IgG or blocking peptide was used. Cells were examined using a fluorescence microscope (Leica DMRA).
Immunocytochemistry
To detect the differentiation of testis-derived ES-like cells into particular lineages, immunocytochemistry was applied with the following antibodies: for neural derivatives, anti-neurofilament (NF, RT97, HybridomaBank, The University of Iowa, Iowa) and anti-glial fibrillary acidic protein (GFAP, Z 0334, DakoCytomation, Glosturp, Denmark); for epidermal cell differentiation, anti-cytokeratin 14 (CK14, B429) (sc-58 723, Santa Cruz); for osteogenic differentiation, anti-osteocalcin (OC-30, ab-134180, Abcam); for myogenic differentiation, anti-a-smooth muscle actin antibody (MU128-UC, BioGenex, San Ramon, CA); and for insulin-producing cells, anti-c-peptide (RE11 247C100, BioVendor, Candler, North Carolina). Formalin-fixed cells were treated with Triton X-100 and endogenous peroxidase was blocked with 0.35% peroxidase. After blocking with 5% goat serum and 1% BSA, and overnight incubation with the primary antibody at 48C, cells were incubated with PowerVision poly HRP-anti-mouse IgG, (#DPVM-110HRP, Immunologic, ImmunoVision Tech. Co., Brisbane, CA) for 30 min at room temperature, and signal was visualized with 3,3 0 -diaminobenzidinetetrahydrochloride and counterstained with hematoxylin. The following reference tissues were used as positive controls: brain tissue for NF and GFAP stainings, skin tissue for CK14 staining, testis tissue for a-SMA staining, placenta tissue for OC-30 staining and pancreas tissue for c-peptide staining. The corresponding IgGs were applied to differentiated ES-like cells as a negative control.
Alkaline phosphatase activity
Alkaline phosphatase activity as a marker for undifferentiated ES-like cells was demonstrated with NBT/BCIP (Roche) according to the manufacturer's instructions.
Histochemical stainings
To detect insoluble calcium and phosphate deposition, Alizarin Red S and von Kossa staining were performed, respectively (Sottile et al., 2003; Huitema et al., 2006; Zheng et al., 2006) .
To show the lipid droplet accumulations within the cells, Oil Red O staining was performed (Pittenger et al., 1999) .
Quantification of insulin secretion
Secreted insulin in culture medium was detected with the IMMULITE @ 2000 Insulin kit (L2KIN2, Siemens). Medium was collected from differentiated cells cultured for 8 h without N-2 supplement (Invitrogen) and serum to check the basal insulin secretion. To detect glucose-induced insulin release, 10-mM glucose in Krebs-Ringer bicarbonate solution was added to the differentiated cells for 2.5 h as described previously (Sagev et al., 2004) after an initial culture of 5.5 h in medium without N-2 supplement and serum.
Teratoma induction
Testis-derived ES-like cells in matrigel were injected into NMRI nu/nu mice (Charles River, The Netherlands) or severe combined immunodeficient (SCID) beige mice (Charles River Laboratories, France) (Supplementary Table S2 ). The procedures were approved and performed according to the regulations provided by the animal ethics committee of the Academic Medical Center of the University of Amsterdam and the Barcelona Biomedical Research Park. Mice were sacrificed 9 -20 weeks post-injection and the injection sites were dissected and microscopically assessed for the presence of teratomas using standard Embryonic stem cell-like cells from human testis hematoxylin/eosin staining. To detect the presence of remaining cells of human origin at the transplanted site, we performed HLA immunostaining on cryosections, which were treated with 0.1% Triton X-100, 5% goat serum and 1% BSA in PBS for 30 min at RT and subsequently with HLA-ABC:fITC antibody for an hour at RT. For the secondary antibody, the sections were submerged into biotin conjugated goat anti-mouse antibody and finally the signal was detected with the AEC system (Sigma-Aldrich).
Karyotyping
To study the chromosomal stability, ES-like cells were synchronized in the cell cycle by starvation for 48 h using serum deprivation culture conditions. Cells were treated with Colcemid (Gibco 15 210-057), trypsinized, resuspended in 75-mM KCl hypotonic solution, fixed in MeOH/acetic Acid (3:1) and stained for metaphase spreads using a standard technique (Barch et al., 1997) . For each cell line, at least 30 metaphase spreads were examined.
Bisulphite sequencing
Methylation status of H19, Pou5f1 and Nanog was investigated in ES-like cells using enriched SSCs as a reference. To obtain enriched SSCs, we performed CD49f (Biolegend 313604) positive cell selection on testicular cells using miniMACS TM separation system (Miltenyi Biotec 130-090-312) in accordance with manufacture's protocol.
Genomic DNA was extracted and conversion of unmethylated cytosines to uracil was carried out using the EpiTect Bisulphite kit (#59 104, QIAGEN) according to the manufacturer's protocol. For each reaction 2 mg of DNA was treated with bisulfite and one-fifth of that converted DNA was used as input for each PCR reaction. Primers for Pou5f1 and Nanog were as described by Deb-Rinker et al. (2005) and the primers for H19 were as described by Conrad et al. (2008) . PCR was performed as follows: initial denaturation for 10 min at 958C and 38 cycles of 958C for 1 min, 588C for 1 min and 728C for 1 min for Pou5f1 and Nanog and 38 cycles of 958C for 1 min, 538C for 1 min and 728C for 1 min for H19 and followed by 728C for 10 min. The resultant products were cleaned up with QIAquick PCR purification kit (#28 104, QIAGEN) and cloned (TOPO-TA cloning, Invitrogen) and after that were sequenced. Resultant sequences were aligned to the DNA sequences of the selected loci of the gene of interest on the website of quantification tool for methylation analysis (http://quma.cdb.riken.jp/top/index.html).
Results
Testicular cells were isolated and cultured from testis samples with normal or focal spermatogenesis of four men (Table I ). In the cultures of all four samples, we observed the appearance of sharp-edged and compact colonies (Fig. 1A ) that resembled true hES colonies. We designated these colonies as ES-like colonies. The number of human testis-derived ES-like colonies that developed in each culture experiment varied between one and more than 90 colonies (Table I ). All colonies appeared between 3 and 8 weeks after the initiation of the primary cultures and these colonies could be further subcultured using hES cell-specific conditions on matrigel-coated dishes without a feeder layer for at least 15 weeks for 13 passages (Fig. 1B) . Cells were passaged 1:3 every week with an estimated doubling time of 96 h (http://www.chestx-ray.com/SPN/DoublingTime.html) and could be successfully frozen and thawed multiple times.
When subcultured under hES cell-specific conditions, the ES-like cells displayed strong alkaline phosphatase activity (Fig. 1C) and expressed hES cell-specific transcription factors (POU5F1, NANOG, SOX2) and surface markers (SSEA4, TRA-1-60, TRA-1-81) (Fig. 1D) . Similarly to hES cells, human testicular-derived ES-like cells were negative for SSEA1 (Fig. 1D) . At the transcript level, ES-like cells showed expression of hES cell-specific genes that remained expressed throughout the length of the cultures (Fig. 2) .
Upon exposure to in vitro directed differentiation conditions, ES-like cells showed the potential to differentiate into derivatives of all three germ layers. More precisely, we confirmed differentiation into the Embryonic stem cell-like cells from human testis neural lineage by staining with neurofilament (NF) and glial fibrillary acidic protein (GFAP) (Fig. 3) . ES-like cells that differentiated into the epithelial lineage stained positive for cytokeratin14 (CK14) while ES-like cells that differentiated into the myogenic lineage stained positive for alpha smooth muscle actin (a-SMA) (Fig. 3) . Osteogenic cells derived from ES-like cells clearly showed a layered structure typical of cartilage and stained positive for OC-30, and ES-like cells also had the potential of differentiation into the pancreatic lineage as demonstrated by the presence of c-peptide, i.e. the precursor of insulin (Fig. 3) .
Besides the changes in expression upon differentiation as described above, the ES-like cells also showed morphological changes like the formation of islets upon pancreatic differentiation (Fig. 4A) and the presence of multinucleated elongated cells after myogenic differentiation (Fig. 4B) . Furthermore, we occasionally observed spontaneous differentiation of ES-like cells into cells with typical adipocyte morphology and accumulation of lipid ( Fig. 4C and D) .
We then studied the functionality of the differentiated ES-like cells. ES-like cells directed towards pancreatic differentiation were able to increase insulin secretion upon exposure to glucose (Fig. 5A ). In addition, ES-like cells directed towards osteogenic differentiation deposited both calcium and phosphate (Fig. 5B) .
ES-like cells from three patients (URO0008 ES-like clone 2 passage 8, URO0012 ES-like clone 2 passage 12 and URO0021 ES-like clone 2 passage 9) were karyotyped and all three showed a normal 46 XY karyotype (Fig. 6) .
We also studied the methylation status of H19, Pou5f1 and Nanog in enriched SSCs and ES-like clones from all patients. As compared with enriched SSCs, the ES-like cells showed increased demethylation for all three genes (Fig. 7) .
To investigate the ability of ES-like cells to give rise to teratomas, we injected a total of 44 mice of two different immunocompromised strains commonly used to assay teratoma (NMRI nu/nu and SCID) with varying amounts of cells (from 10 6 to 10 7 cells per injection) from early and later passages (passage number ranging from 4 to 7) at several injection sites (subcutaneous, i.m. and intratesticular). Mice were sacrificed and analyzed for teratoma formation after 9 -20 weeks (Supplementary Table S2 ). Although we observed small areas with differentiated cell types of human origin (Fig. 8) , we did not observe extensive teratomas in any of the 44 injected mice, whereas hES or iPS cells injected in parallel readily gave rise to complex teratomas (data not shown).
Discussion
Our results demonstrate the spontaneous in vitro generation of ES-like cells from adult human testis under conditions known to support longterm proliferation of SSCs. These ES-like cells expressed hES cellspecific markers, and could be subcultured for 15 weeks and stay karyotypically normal. In addition these ES-like cells could differentiate into cells of all germ layers in vitro and produce functional beta cells and adipocytes, but did not contribute to teratoma formation in vivo. As such, these ES-like cells could potentially be highly useful for future stem cell-based clinical therapies. The difference between our study and the very recently published studies (Conrad et al., 2008; Golestaneh et al., 2009; Kossack et al., 2009) on human ES-like cells from adult testis lies in the culture method used. To generate ES-like colonies, we used culture conditions known to support the long-term proliferation of SSCs (Kanatsu-Shinohara et al., 2004) , whereas the others used culture conditions that favor the growth of ES cells. Our results together with the previous papers on ES-like cells derived from adult human testis indicate that the culture conditions used to generate ES-like cells are not that critical. Future studies should determine the most efficient method to generate ES-like cells from human testis.
Although the ES-like colonies in our experiments arose from human testicular cells that support SSCs, the precise origin of these cells remains to be established since we did not use a rigorous preselection procedure but rather used a mixed culture system of various testicular cells, including Sertoli and peritubular cells. Studies in mice using GPR125 as a germ cell marker indicate that the ES-like cells are of germ cell origin, making SSCs the most likely candidates (Guan et al., 2006; Seandel et al., 2007) . Unfortunately, no unique human or mouse SSC markers are currently available to address this question directly.
Although we succeeded in the generation of ES-like colonies from all four men included in our study, the occurrence of these colonies seemed a stochastic, and as yet uncontrollable, process and as a result the number of colonies derived from each sample varied. This variation might depend on the age of the patient and/or the number of stem cells present within the testis biopsy. Future studies Embryonic stem cell-like cells from human testis will need to determine the precise pathway by which ES-like cells arise from human testis to both control the timing of their occurrence and to increase the efficiency of the procedure.
Teratoma formation is a hallmark of pluripotent cells but, at the same time, constitutes a major drawback for their potential therapeutic application. Although we were able to show the presence of human cells at the injection site 9 weeks post-injection, we did not observe teratomas in any of the 44 injected mice. The human testisderived ES-like cells recently described showed in general organized but rather small-sized non-extensive teratoma formation upon injection into immunocompromised mice and not in all cases (Conrad et al., 2008; Golestaneh et al., 2009; Kossack et al., 2009) . This suggests that the ES-like cells derived from human testis might have lost some of their pluripotency or may have not been fully reprogrammed to pluripotency during their culture in vitro.
In conclusion, our results show that adult human testis-derived ES-like cells can differentiate into cell types of all germ layers with functional capabilities in vitro. Thus, testis-derived human ES-like cells are potentially useful for future stem cell-based clinical therapies as part of regenerative medicine. Their easy accessibility and ethical acceptance make these cells an attractive alternative to human ES cells, at least for male patients. 
